Innovation Solutions

  1. Recombinant Protein Production 5/28/2026

    Curia has decades of experience in recombinant protein production.

  2. Small Molecules Discovery 5/28/2026

    Whether you require a particular expertise or a complete, experienced integrated small molecule discovery team, Curia can provide a high-performance solution to help turn your vision into reality.

  3. Custom Synthesis Services 5/28/2026

    For more than 30 years Curia has been meeting the custom synthesis needs of our clients.

  4. Integrated Drug Discovery 5/28/2026

    Integrated drug discovery greatly benefits programs by blending various scientific disciplines into a unified team focused on your project.

  5. Medicinal Chemistry 5/28/2026

    Curia was the first CRO to provide contract medicinal chemistry services to the pharmaceutical industry.

  6. Structural Biology Services 5/28/2026

    At Curia, our team of expert protein chemists and structural biologists brings the advanced experience and technology needed to support all your structural biology services needs.

  7. Commercial-Scale, Single-Use Tangential Flow Filtration System 1/7/2026

    Achieve efficient, automated filtration for biopharmaceutical production with a system offering high throughput that is designed for ultrafiltration, diafiltration, and microfiltration.

  8. An Organ-Chip Platform That Generates Human-Relevant Data At Scale 12/18/2025

    Generate human-relevant data with an Organ-Chip system that combines automation, imaging, and cost efficiency for faster, more confident insights for drug development and complex biological studies.

  9. A Revolutionary Consumable Empowering High-Throughput Organ-Chip Studies 12/18/2025

    With 12 independent Emulations in one consumable, Chip-Array optimizes workflows and reduces cell requirements—delivering scalable, physiologically relevant models for advanced research.

  10. Complete Organ-Chip Solutions To Fast-Track Your Drug Discovery 12/18/2025

    From cancer models to high-throughput screening, Organ-Chip platforms accelerate development, improve safety, and support regulatory compliance for next-generation therapies.